Literature DB >> 14706223

In vitro effects of D-2-hydroxyglutaric acid on glutamate binding, uptake and release in cerebral cortex of rats.

Débora Junqueira1, Ana M Brusque, Lisiane O Porciúncula, Liane N Rotta, Marcos E S Frizzo, Angela T S Wyse, Clóvis M D Wannmacher, Diogo O Souza, Moacir Wajner.   

Abstract

Neurological dysfunction is common in patients with D-2-hydroxyglutaric aciduria (DHGA). However, the mechanisms underlying the neuropathology of this disorder are far from understood. In the present study, we investigated the in vitro effects of D-2-hydroxyglutaric acid (DGA) at various concentrations (0.1-1.0 mM) on various parameters of the glutamatergic system, namely the basal and potassium-induced release of L-[3H]glutamate by synaptosomal preparations, Na(+)-dependent L-[3H]glutamate uptake by synaptosomal preparations and Na(+)-independent L-[3H]glutamate uptake by synaptic vesicles, as well as of Na(+)-independent and dependent L-[3H]glutamate binding to synaptic plasma membranes from cerebral cortex of male adult Wistar rats. We observed that DGA significantly increased synaptosomal L-[3H]glutamate uptake, without altering the other parameters. Although these findings do not support a direct excitotoxic action for DGA since the metabolite did not affect important parameters of the main neurotransmission system, they do not exclude a direct action of DGA on NMDA or other glutamate receptors. More comprehensive studies are therefore necessary to evaluate the exact role of DGA on neurotransmission.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14706223     DOI: 10.1016/j.jns.2003.10.005

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  Tumor-related molecular determinants of neurocognitive deficits in patients with diffuse glioma.

Authors:  Emma van Kessel; Sharon Berendsen; Anniek E Baumfalk; Hema Venugopal; Eva A Krijnen; Wim G M Spliet; Wim van Hecke; Fabrizio Giuliani; Tatjana Seute; Martine J E van Zandvoort; Tom J Snijders; Pierre A Robe
Journal:  Neuro Oncol       Date:  2022-10-03       Impact factor: 13.029

2.  IDH-mutated gliomas promote epileptogenesis through d-2-hydroxyglutarate-dependent mTOR hyperactivation.

Authors:  Armin Mortazavi; Islam Fayed; Muzna Bachani; Tyrone Dowdy; Jahandar Jahanipour; Anas Khan; Jemima Owotade; Stuart Walbridge; Sara K Inati; Joseph Steiner; Jing Wu; Mark Gilbert; Chun Zhang Yang; Mioara Larion; Dragan Maric; Alexander Ksendzovsky; Kareem A Zaghloul
Journal:  Neuro Oncol       Date:  2022-09-01       Impact factor: 13.029

Review 3.  The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies.

Authors:  M Wajner; A Latini; A T S Wyse; C S Dutra-Filho
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 4.  Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy.

Authors:  Terri S Armstrong; Robin Grant; Mark R Gilbert; Jong Woo Lee; Andrew D Norden
Journal:  Neuro Oncol       Date:  2015-11-02       Impact factor: 12.300

Review 5.  Progress in understanding 2-hydroxyglutaric acidurias.

Authors:  Martijn Kranendijk; Eduard A Struys; Gajja S Salomons; Marjo S Van der Knaap; Cornelis Jakobs
Journal:  J Inherit Metab Dis       Date:  2012-03-06       Impact factor: 4.982

Review 6.  The Roles of 2-Hydroxyglutarate.

Authors:  Xin Du; Hai Hu
Journal:  Front Cell Dev Biol       Date:  2021-03-26

7.  Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development.

Authors:  Erwin E W Jansen; Eduard Struys; Cornelis Jakobs; Elizabeth Hager; O Carter Snead; K Michael Gibson
Journal:  BMC Dev Biol       Date:  2008-11-28       Impact factor: 1.978

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.